Boule Diagnostics AB (OSTO:BOUL)

Q3 2025 Boule Diagnostics AB Earnings Call Transcript

Oct 24, 2025 / 08:00 AM GMT

Release Date Price: kr5.26 (+7.35%)

Transcript

Key Points

Positve

Boule Diagnostics AB (OSTO:BOUL) returned to organic growth with a 1.7% increase in sales despite a 4.1% unfavorable currency impact.
The company achieved a positive operating cash flow for the second consecutive quarter.
Instrument sales were strong, growing by 16%, supported by high sales of a 5-part instrument.
The company signed a Technology Partner supply agreement for a new veterinary instrument set to launch in 2026.
Operating expenses decreased significantly by 30% compared to the previous year, reflecting successful restructuring efforts.

Negative

Gross profit decreased from 61 million to 52.4 million due to lower instrument pricing and the impact of a weakened US dollar.
Gross margin declined to 41.2% from 46.8%, although there was a slight improvement over the previous quarter.
The company faced currency headwinds, particularly from a stronger SEK and a weaker US dollar, affecting gross margins.
OEM sales were flat when adjusted for currency, with a negative currency impact of 10% in the quarter.
The company experienced delayed payments and unfavorable effects impacting reagent sales.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

BOUL.ST - Boule Diagnostics AB
Q3 2025 Boule Diagnostics AB Earnings Call
Oct 24, 2025 / 08:00AM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Good morning everybody and welcome to the 3rd quarter's earnings call for Boo Diagnostics. I'm O Lambe, CEO for Google Diagnostics, and with me, I have our CEO Toby Nilsson.

After the presentation, we will open up for questions.

Please also feel free to ask questions in the chat field. With that, I'm handing over to our CEO Tennison.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
Thank you, Holger.

In the 3rd quarter, we return to organic growth in a market that continues to face structural challenges.

Although we still suffer from currency

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

7-Day Free Trial · Cancel Anytime

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.